Detalhe da pesquisa
1.
De Novo Variants in SPOP Cause Two Clinically Distinct Neurodevelopmental Disorders.
Am J Hum Genet
; 106(3): 405-411, 2020 03 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32109420
2.
Inhibition of the proline metabolism rate-limiting enzyme P5CS allows proliferation of glutamine-restricted cancer cells.
Nat Metab
; 5(12): 2131-2147, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37957387
3.
SPOP-mutant prostate cancer: Translating fundamental biology into patient care.
Cancer Lett
; 529: 11-18, 2022 03 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-34974131
4.
Co-occurrence and mutual exclusivity: what cross-cancer mutation patterns can tell us.
Trends Cancer
; 7(9): 823-836, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34031014
5.
Dual functions of SPOP and ERG dictate androgen therapy responses in prostate cancer.
Nat Commun
; 12(1): 734, 2021 02 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33531470
6.
Opposing effects of cancer-type-specific SPOP mutants on BET protein degradation and sensitivity to BET inhibitors.
Nat Med
; 23(9): 1046-1054, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28805821
7.
TRIM24 Is an Oncogenic Transcriptional Activator in Prostate Cancer.
Cancer Cell
; 29(6): 846-858, 2016 06 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-27238081
8.
Interaction of CDCP1 with HER2 enhances HER2-driven tumorigenesis and promotes trastuzumab resistance in breast cancer.
Cell Rep
; 11(4): 564-76, 2015 Apr 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-25892239